- Home
- TAOP vs QNRX Comparison
TAOP vs QNRX Comparison
Compare TAOP & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAOP | QNRX |
|---|---|---|
| Founded | 1993 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 14.5M |
| IPO Year | 2012 | 2023 |
Fundamental Metrics
Financial Performance| Metric | TAOP | QNRX |
|---|---|---|
| Price | $1.24 | $5.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.4K | ★ 38.5K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $5.47 |
| 52 Week High | $8.78 | $41.80 |
Technical Indicators
Market Signals| Indicator | TAOP | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 36.36 |
| Support Level | $1.20 | $5.47 |
| Resistance Level | $1.59 | $6.98 |
| Average True Range (ATR) | 0.07 | 0.52 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 20.00 | 19.88 |
Price Performance
Historical ComparisonAbout TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.